Billiontoone Inc Revenue Growth Rates (BLLN), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Billiontoone Inc   (NASDAQ: BLLN)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

BLLN's Revenue Growth by Quarter and Year

Billiontoone Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BLLN Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 109.45
1st Quarter March 108.10
FY 217.55





BLLN Revenue second quarter 2026 Y/Y Growth Comment
Billiontoone Inc reported Revenue surge of 64.41% year on year in the second quarter 2026, to $ 109.45 millions, this is lower than Billiontoone Inc 's recent average Revenue rise of 88.28%.

Looking into second quarter 2026 results within Medical Laboratories industry 2 other companies have achieved higher Revenue growth. While Billiontoone Inc ' s Revenue jump of 64.41% ranks overall at the positon no. 380 in the second quarter 2026.


BLLN Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December - 150 % - -
3rd Quarter September - - - -
2nd Quarter June 64.41 % - - -
1st Quarter March 83.34 % - - -
FY   - 693.86 % - -

Financial Statements
Billiontoone Inc 's second quarter 2026 Revenue $ 109.45 millions BLLN's Income Statement
Billiontoone Inc 's second quarter 2025 Revenue $ 66.57 millions Quarterly BLLN's Income Statement


BLLN Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - 15.14 % - -
3rd Quarter September - 25.31 % - -
2nd Quarter June 1.25 % 12.91 % - -
1st Quarter March 12.55 % 53.46 % - -
FY (Year on Year)   - 693.86 % - -


Back to BLLN Growth rate Comparisons >> Back to BLLN Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #3
Healthcare Sector #101
Overall #380

Revenue Y/Y Growth Statistics
High Average Low
117.12 % 88.28 % 64.4 %
(Dec 31 2025)   (Mar 31 2026)
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #3
Healthcare Sector #101
Overall #380
Revenue Y/Y Growth Statistics
High Average Low
117.12 % 88.28 % 64.4 %
(Dec 31 2025)   (Mar 31 2026)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Billiontoone Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
165.64 % 30.78 % -51.22 %
(Dec 31 2025)  


BLLN's II. Quarter Q/Q Revenue Comment
Billiontoone Inc achieved in the II. Quarter 2026 below company average Revenue growth of 1.25% quarter on quarter, to $ 109.45 millions.

Within Medical Laboratories industry 11 other companies have achieved higher Revenue quarter on quarter growth. While Billiontoone Inc 's Revenue growth quarter on quarter, overall rank is 1581.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #12
Healthcare Sector #215
Overall #1581
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #12
Healthcare Sector #215
Overall #1581
Revenue Q/Q Growth Statistics
High Average Low
165.64 % 30.78 % -51.22 %
(Dec 31 2025)  


BLLN's II. Quarter Q/Q Revenue Comment
Billiontoone Inc achieved in the II. Quarter 2026 below company average Revenue growth of 1.25% quarter on quarter, to $ 109.45 millions.

Within Medical Laboratories industry 11 other companies have achieved higher Revenue quarter on quarter growth. While Billiontoone Inc 's Revenue growth quarter on quarter, overall rank is 1581.


Billiontoone Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
 12 Months Ending
Cumulative Revenue 12 Months Ending $ 0.00 $ 0.00 $ 83.42 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) - - - - -
Seq. Revenue Growth (TTM) Overall Ranking # # # # #


Cumulative Revenue growth Comment
In the Mar 31 2026 period, Billiontoone Inc 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Billiontoone Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
 0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Revenue growth Comment
In the Mar 31 2026 period, Billiontoone Inc 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Billiontoone Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Revenue Growth
Medical Laboratories Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
BLLN's Revenue Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue growth for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Foghorn Therapeutics Inc 112.68%$ 112.677 millions
60 Degrees Pharmaceuticals Inc 106.04%$ 106.044 millions
Mobia Medical Inc 102.35%$ 102.352 millions
Ptc Therapeutics inc 101.55%$ 101.548 millions
Eton Pharmaceuticals Inc 98.63%$ 98.631 millions
Immunitybio inc 93.91%$ 93.907 millions
Syndax Pharmaceuticals Inc 91.76%$ 91.759 millions
Phathom Pharmaceuticals Inc 88.02%$ 88.021 millions
Fennec Pharmaceuticals Inc 85.18%$ 85.184 millions
Alamar Biosciences Inc 82.08%$ 82.075 millions
Seastar Medical Holding Corp81.95%$ 81.953 millions
Sera Prognostics Inc 76.47%$ 76.471 millions
Innovative Eyewear Inc 74.46%$ 74.459 millions
Madrigal Pharmaceuticals Inc 71.17%$ 71.169 millions
Tg Therapeutics Inc 70.27%$ 70.272 millions
Tarsus Pharmaceuticals Inc 69.41%$ 69.406 millions
Hyperfine Inc 67.70%$ 67.698 millions
Alnylam Pharmaceuticals Inc 66.86%$ 66.856 millions
Emergent Biosolutions Inc 66.29%$ 66.288 millions
Vivos Therapeutics Inc 65.69%$ 65.691 millions
Iovance Biotherapeutics inc 65.65%$ 65.654 millions
Billiontoone Inc 64.40%$ 64.403 millions
Anteris Technologies Global Corp 63.27%$ 63.269 millions
Nexgel Inc 63.24%$ 63.242 millions
Carlsmed Inc 59.58%$ 59.575 millions
Sonoma Pharmaceuticals Inc 59.55%$ 59.552 millions
Arcutis Biotherapeutics Inc 59.33%$ 59.331 millions
Nephros Inc 58.55%$ 58.551 millions
Bioadaptives Inc 54.95%$ 54.955 millions
Zevra Therapeutics Inc 53.25%$ 53.251 millions


About Billiontoone Inc Revenue Growth Rates (BLLN), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Billiontoone Inc (CIK 2070849).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0002070849-26-000050
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Billiontoone Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.